SUBSCRIBE
SUBSCRIBE
News   Drug Development

Genmab A/S Announces Start of Ofatumumab Phase III Head to Head Study in DLBCL

November 9, 2009 | 
1 min read

COPENHAGEN, Denmark, Nov. 9, 2009 (GLOBE NEWSWIRE) -- Summary: Genmab has initiated a Phase III study of Arzerra ofatumumab in diffuse large B-cell lymphoma.

Clinical research Phase III Europe
MORE ON THIS TOPIC
Pictured: Boehringer Ingelheim sign on a building/
Schizophrenia
Boehringer Suffers Phase III Schizophrenia Fail, Legal Parry by HHS
January 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Businessman jump careful on cracked or broken graph. Job opportunity and career. concept of under pressure. risk, financial, and tax
Pipeline
New Safety Signals Force Keros to Fully Terminate Mid-Stage PAH Study
January 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Business
Dispatches From JPM, Biogen’s Sage Buyout Offer, Pfizer’s Obesity Play, More
January 15, 2025
 · 
1 min read
 · 
Heather McKenzie
Pictured: A sign on a J.P. Morgan building in Hong Kong/iStock, danielvfung
Pipeline
JPM25 Day One: Pfizer, BioNTech, Moderna and More Present Pipeline Updates
January 14, 2025
 · 
3 min read
 · 
Dan Samorodnitsky